免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Anthogyr AXIOM® BL X3植入物,Anthogyr Multi-Unit组件用于AXIOM® BL

K号: K230104 · 2023-10-16

申请人Anthogyr
决定日期2023-10-16
产品代码DZE
咨询委员会DE 请注意,您没有提供具体的医疗设备监管文本内容,因此我无法进行翻译。请提供需要翻译的具体文本,我将根据您的要求进行翻译。
决定实质等同

器械摘要

Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL is the device name listed in this FDA 510(k) record. The listed applicant is Anthogyr. It received FDA 510(k) clearance on 2023-10-16 under 510(k) number K230104. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL?

Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL is a medical device that received FDA 510(k) clearance on 2023-10-16. The listed applicant is Anthogyr. The 510(k) number is K230104.

When did Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL receive FDA 510(k) clearance?

Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL received FDA 510(k) clearance on 2023-10-16, under 510(k) number K230104.

Who is the listed applicant for Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL?

The FDA 510(k) record lists Anthogyr as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL?

The FDA product code for Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL is DZE.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Anthogyr为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:DZE)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑